ASPEN PHARMACARE HOLDINGS LIMITED - Posting of circular and notice of general meeting

Posting of circular and notice of general meeting

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")

POSTING OF CIRCULAR AND NOTICE OF GENERAL MEETING

Shareholders are referred to the announcement released by Aspen on 30 September 2013 in respect of a proposed transaction in
terms whereof Aspen Global Incorporated, a wholly owned subsidiary of Aspen, will acquire from GSK the Arixtra and
Fraxiparine/Fraxodi brands and business worldwide, except in China, Pakistan and India and Aspen will acquire from GSK a specialised
sterile production site which manufactures the Brands at Notre Dame de Bondeville, France, collectively (“the Proposed Transaction”).

Shareholders are advised that the circular relating to the Proposed Transaction was posted to Aspen shareholders, today, 10 October
2013 and that the general meeting of shareholders to approve the transaction will be held at Aspen Park, Building 1, 98 Armstrong
Drive, La Lucia Ridge, Durban at 15:00 on Friday, 8 November 2013. A copy of the circular is available on the Company’s website
http://www.aspenpharma.com/.

Durban
10 October 2013

Sponsor:
Investec Bank Limited

Date: 10/10/2013 05:10:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.